Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers

© 2019, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: The present study aimed to determine the extent of information that healthy volunteers need in an informed consent form (ICF) to support their decision whether to participate in a bioequivalence study, a type of clinical studies...

Full description

Saved in:
Bibliographic Details
Main Authors: Nut Koonrungsesomboon, Saranyapin Potikanond, Mingkwan Na Takuathung, Wutigri Nimlamool, Juntra Karbwang
Format: Journal
Published: 2019
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070824465&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/66727
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-66727
record_format dspace
spelling th-cmuir.6653943832-667272019-09-16T12:59:35Z Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers Nut Koonrungsesomboon Saranyapin Potikanond Mingkwan Na Takuathung Wutigri Nimlamool Juntra Karbwang Medicine Pharmacology, Toxicology and Pharmaceutics © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: The present study aimed to determine the extent of information that healthy volunteers need in an informed consent form (ICF) to support their decision whether to participate in a bioequivalence study, a type of clinical studies involving the testing of pharmacokinetic equivalence of a generic drug with a brand-name drug in volunteer subjects. Methods: This cross-sectional, descriptive study determined the perspectives of individuals who used to participate in bioequivalence studies, using an electronic-based questionnaire. A 5-point modified Likert scale was used to indicate the importance of each element of the ICF content, with an anchored rating scale from 1 (not important) to 5 (very important) for each item. Results: Of 300 questionnaires distributed, all (100%) were returned. The respondents considered most items to be necessary for their decision, with the score ranging from 3.25 to 4.60 (mean overall score = 4.16 ± 0.30). The four top-rated items were the “major foreseeable risk” (4.60 ± 0.72), “participant’s responsibility during participation” (4.52 ± 0.72), “confidentiality and the limit of confidentiality” (4.52 ± 0.82), and “all possible adverse effects of the drug” (4.47 ± 0.74), while the relatively less concerned items were related to general information. Conclusions: Most elements of the ICF content required were considered as important by the previously experienced volunteers in bioequivalence studies, notwithstanding that some elements were perceived as more important than others. The data from this study could be used to better tailor relevant information in an ICF to the needs of research participants in bioequivalence studies. 2019-09-16T12:58:14Z 2019-09-16T12:58:14Z 2019-01-01 Journal 14321041 00316970 2-s2.0-85070824465 10.1007/s00228-019-02738-6 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070824465&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/66727
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
Pharmacology, Toxicology and Pharmaceutics
spellingShingle Medicine
Pharmacology, Toxicology and Pharmaceutics
Nut Koonrungsesomboon
Saranyapin Potikanond
Mingkwan Na Takuathung
Wutigri Nimlamool
Juntra Karbwang
Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
description © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: The present study aimed to determine the extent of information that healthy volunteers need in an informed consent form (ICF) to support their decision whether to participate in a bioequivalence study, a type of clinical studies involving the testing of pharmacokinetic equivalence of a generic drug with a brand-name drug in volunteer subjects. Methods: This cross-sectional, descriptive study determined the perspectives of individuals who used to participate in bioequivalence studies, using an electronic-based questionnaire. A 5-point modified Likert scale was used to indicate the importance of each element of the ICF content, with an anchored rating scale from 1 (not important) to 5 (very important) for each item. Results: Of 300 questionnaires distributed, all (100%) were returned. The respondents considered most items to be necessary for their decision, with the score ranging from 3.25 to 4.60 (mean overall score = 4.16 ± 0.30). The four top-rated items were the “major foreseeable risk” (4.60 ± 0.72), “participant’s responsibility during participation” (4.52 ± 0.72), “confidentiality and the limit of confidentiality” (4.52 ± 0.82), and “all possible adverse effects of the drug” (4.47 ± 0.74), while the relatively less concerned items were related to general information. Conclusions: Most elements of the ICF content required were considered as important by the previously experienced volunteers in bioequivalence studies, notwithstanding that some elements were perceived as more important than others. The data from this study could be used to better tailor relevant information in an ICF to the needs of research participants in bioequivalence studies.
format Journal
author Nut Koonrungsesomboon
Saranyapin Potikanond
Mingkwan Na Takuathung
Wutigri Nimlamool
Juntra Karbwang
author_facet Nut Koonrungsesomboon
Saranyapin Potikanond
Mingkwan Na Takuathung
Wutigri Nimlamool
Juntra Karbwang
author_sort Nut Koonrungsesomboon
title Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
title_short Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
title_full Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
title_fullStr Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
title_full_unstemmed Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
title_sort informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers
publishDate 2019
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070824465&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/66727
_version_ 1681426509017907200